34. Neurofibromatosis Clinical trials / Disease details
Clinical trials : 137 / Drugs : 213 - (DrugBank : 76) / Drug target genes : 87 - Drug target pathways : 200
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00060008 (ClinicalTrials.gov) | April 2002 | 6/5/2003 | Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma | Novel Imaging Modalities For Plexiform Neurofibromas | Neurofibromatosis Type 1;Precancerous Condition | Radiation: fludeoxyglucose F 18;Radiation: gadopentetate dimeglumine | Children's Hospital of Philadelphia | NULL | Terminated | N/A | 25 Years | All | 18 | N/A | United States |